McElhenny Sheffield Capital Management’s Boston Scientific BSX Stock Holding History

McElhenny Sheffield Capital Management’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-4,744	Closed	-$510K	–	107
2025 Q2	$510K	Sell	4,744 -350	-7%	-$35.4K	0.14%	49
2025 Q1	$514K	Buy	+5,094	New	+$513K	0.19%	47
2023 Q4	–	Sell	-12,986	Closed	-$686K	–	92
2023 Q3	$686K	Sell	12,986 -1,762	-12%	-$92.4K	0.35%	26
2023 Q2	$798K	Sell	14,748 -2,194	-13%	-$115K	0.34%	27
2023 Q1	$848K	Sell	16,942 -2,895	-15%	-$136K	0.45%	32
2022 Q4	$918K	Sell	19,837 -3,703	-16%	-$160K	0.42%	28
2022 Q3	$912K	Buy	+23,540	New	+$944K	0.7%	25
2021 Q4	–	Sell	-29,900	Closed	-$1.3M	–	125
2021 Q3	$1.3M	Buy	+29,900	New	+$1.32M	0.59%	18

Other funds holding BSX

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

McElhenny Sheffield Capital Management's BSX Position: Q3 2025 in Review

McElhenny Sheffield Capital Management sold out of Boston Scientific (BSX) in Q3 2025, closing a stake of 4,744 shares — an estimated $510K sold.

McElhenny Sheffield Capital Management first reported a position in BSX in Q3 2021 and held it in 8 quarters. The position peaked at $1.3M in Q3 2021. 1,708 funds tracked by Wall St. Rank hold BSX as of Q3 2025.

McElhenny Sheffield Capital Management reported no remaining Boston Scientific position as of Q3 2025 after selling out during the quarter.
McElhenny Sheffield Capital Management sold 4,744 Boston Scientific shares in Q3 2025, an estimated $510K.
McElhenny Sheffield Capital Management first reported a position in Boston Scientific in Q3 2021 and held it in 8 quarters.
McElhenny Sheffield Capital Management's Boston Scientific position peaked at $1.3M in Q3 2021.
1,708 funds tracked by Wall St. Rank held Boston Scientific as of Q3 2025.

Based on McElhenny Sheffield Capital Management's 13F filing for Q3 2025, filed 21 Oct 2025.